Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease

T Manabe1, T Katayama, N Sato

  • 1Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Japan.

Insights

Aberrant splicing of the Presenilin-2 gene (PS2V) is linked to Alzheimer's disease (AD). Hypoxia induces the high mobility group A1a protein (HMGA1a), which causes PS2V by disrupting splicing, offering a new AD mechanism.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Aberrant splicing of the Presenilin-2 (PS2) gene, producing the PS2V isoform, is a hallmark of sporadic Alzheimer's disease (AD).
  • The molecular mechanisms driving this aberrant splicing in AD remain largely unknown.

Purpose of the Study:

  • To identify the trans-acting factors responsible for hypoxia-induced PS2V generation.
  • To elucidate the role of these factors in the pathogenesis of sporadic AD.

Main Methods:

  • Hypoxia induction in human neuroblastoma cells (SK-N-SH).
  • Purification and identification of a trans-acting factor binding to PS2 exon 5.
  • Overexpression studies of identified factor and splicing factors.
  • Analysis of HMGA1a levels in brain tissue from sporadic AD patients.

Main Results:

  • PS2V splicing is induced by hypoxia in neuronal cells.
  • High mobility group A1a protein (HMGA1a) was identified as the hypoxia-inducible factor binding to PS2 exon 5.
  • HMGA1a overexpression promotes PS2V formation by interfering with U1 snRNP binding, leading to exon 5 skipping.
  • HMGA1a levels are significantly elevated in the brains of sporadic AD patients.

Conclusions:

  • HMGA1a is a key mediator of hypoxia-induced aberrant PS2 splicing.
  • HMGA1a-driven PS2V generation represents a novel molecular mechanism in sporadic Alzheimer's disease pathogenesis.
  • Targeting HMGA1a may offer a therapeutic strategy for sporadic AD.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...